Profile data is unavailable for this security.
About the company
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
- Revenue in USD (TTM)3.40m
- Net income in USD-7.52m
- Incorporated2008
- Employees53.00
- LocationApplied DNA Sciences Inc50 Health Sciences DriveSTONY BROOK 11790United StatesUSA
- Phone+1 (631) 240-8800
- Fax+1 (631) 240-8900
- Websitehttps://adnas.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dror Ortho-Design Inc | 0.00 | -5.63m | 9.41m | 4.00 | -- | 5.68 | -- | -- | -0.012 | -0.012 | 0.00 | 0.0034 | 0.00 | -- | -- | -- | -577.48 | -140.50 | -1,394.24 | -- | -- | -- | -- | -118,188.00 | -- | -- | 0.00 | -- | -- | -- | -1,896.02 | -- | -- | -- |
| Precipio Inc | 16.72m | -3.83m | 9.90m | 51.00 | -- | 0.8103 | -- | 0.5921 | -2.68 | -2.68 | 11.73 | 8.24 | 0.9089 | 17.12 | 16.80 | 327,843.10 | -20.82 | -44.98 | -27.94 | -58.68 | 39.08 | 28.80 | -22.90 | -118.07 | 0.590 | -192.59 | 0.0517 | -- | 61.46 | 39.62 | 52.04 | -- | 5.37 | -- |
| Vivos Therapeutics Inc | 14.02m | -12.05m | 10.48m | 114.00 | -- | 1.65 | -- | 0.7472 | -6.98 | -6.98 | 6.88 | 1.87 | 0.9477 | -- | 38.84 | 123,000.00 | -81.41 | -89.72 | -166.05 | -149.70 | 60.08 | 70.20 | -85.90 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
| Bionoid Pharma Inc | 0.00 | 1.35m | 10.80m | 13.00 | 0.1764 | -- | 7.98 | -- | 1.13 | 1.13 | 0.00 | -0.1744 | -- | -- | -- | -- | -- | -506.64 | -- | -- | -- | -- | -- | -- | -- | 327.24 | -- | -- | -- | -- | -31.55 | -- | 26.01 | -- |
| PetVivo Holdings Inc | 975.28k | -10.11m | 11.00m | 20.00 | -- | 13.20 | -- | 11.28 | -0.6705 | -0.6705 | 0.062 | 0.0417 | 0.3257 | 0.405 | 16.37 | 48,764.00 | -337.63 | -230.77 | -589.09 | -467.99 | 83.60 | 66.21 | -1,036.50 | -1,501.44 | 0.455 | -1,075.05 | 0.0221 | -- | 5.62 | -- | -25.67 | -- | 23.91 | -- |
| Scientific Industries Inc | 10.45m | -7.76m | 12.29m | 63.00 | -- | 1.05 | -- | 1.18 | -0.9231 | -0.9231 | 1.17 | 1.11 | 0.7343 | 1.13 | 9.08 | 165,942.90 | -54.50 | -- | -62.11 | -- | 45.41 | -- | -74.22 | -- | 3.15 | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Dalrada Financial Corporation | 32.16m | -21.34m | 12.62m | 0.00 | -- | 1.43 | -- | 0.3924 | -0.2388 | -0.2388 | 0.3573 | 0.091 | 1.09 | 8.86 | 3.37 | -- | -75.10 | -80.63 | -239.06 | -- | 30.11 | 39.23 | -68.78 | -63.94 | 1.24 | -21.54 | 0.3452 | -- | 54.35 | -- | -43.94 | -- | -- | -- |
| STRATA Skin Sciences Inc | 32.73m | -8.31m | 12.64m | 99.00 | -- | 1.12 | -- | 0.3862 | -2.37 | -2.37 | 9.35 | 2.71 | 0.6906 | 3.47 | 7.81 | 330,606.10 | -17.54 | -11.48 | -24.26 | -16.55 | 54.30 | 61.28 | -25.40 | -17.70 | 0.9176 | -2.69 | 0.6141 | -- | -7.75 | 2.24 | -95.17 | -- | 23.29 | -- |
| Applied DNA Sciences Inc | 3.40m | -7.52m | 12.82m | 53.00 | -- | 1.03 | -- | 3.77 | -11.86 | -11.86 | 2.18 | 1.20 | 0.2092 | 6.83 | 5.68 | 64,114.15 | -45.51 | -88.57 | -55.20 | -121.91 | 25.04 | 44.35 | -217.48 | -113.26 | 3.76 | -- | 0.00 | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
| Trinity Biotech plc (ADR) | 58.65m | -22.29m | 14.44m | 380.00 | -- | -- | -- | 0.2462 | -2.74 | -2.74 | 7.23 | -19.24 | 0.7052 | 1.69 | 3.74 | 154,347.40 | -26.80 | -20.30 | -35.44 | -29.54 | 34.28 | 39.92 | -38.01 | -29.86 | 0.8936 | -2.16 | 1.46 | -- | -9.10 | -10.15 | 15.41 | -- | -31.08 | -- |
| QT Imaging Holdings Inc | 0.00 | -4.02m | 14.58m | -- | -- | 0.6705 | -- | -- | -0.3999 | -0.3999 | 0.00 | 1.01 | 0.00 | -- | -- | -- | -12.32 | -- | -16.60 | -- | -- | -- | -- | -- | -- | -- | 0.3042 | -- | -- | -- | -45.07 | -- | -- | -- |
| REMSleep Holdings Inc | 144.88k | -1.81m | 14.64m | 6.00 | -- | 25.45 | -- | 101.02 | -0.0012 | -0.0012 | 0.0001 | 0.0004 | 0.08 | 1.69 | 4.75 | -- | -99.82 | -152.40 | -122.32 | -317.98 | -491.08 | -- | -1,246.94 | -2,317.52 | 1.47 | -43.58 | 0.1207 | -- | -36.48 | -- | 12.13 | -- | 28.26 | -- |
| Autonomix Medical Inc | -100.00bn | -100.00bn | 14.85m | 5.00 | -- | 2.35 | -- | -- | -- | -- | -- | 0.2749 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.1647 | -- | -- | -- | -674.99 | -- | -- | -- |
| LiveCare Inc | 0.00 | -2.34m | 15.26m | -- | -- | 6.47 | -- | -- | -0.1411 | -0.1411 | 0.00 | 0.0463 | 0.00 | -- | -- | -- | -424.83 | -- | -550.62 | -- | -- | -- | -- | -- | -- | -8.18 | 0.1888 | -- | -- | -- | -344.86 | -- | -- | -- |
| Cutera Inc | 169.19m | -148.97m | 15.28m | 430.00 | -- | -- | -- | 0.0903 | -7.46 | -7.46 | 8.46 | -10.73 | 0.4572 | 2.08 | 3.86 | 393,460.50 | -40.25 | -22.00 | -51.64 | -30.72 | 8.18 | 47.63 | -88.05 | -27.24 | 2.17 | -31.34 | 2.05 | -- | -15.86 | 5.47 | -97.76 | -- | 85.87 | -- |
| BioRegenx Inc | 634.81k | -727.95k | 15.41m | 10.00 | -- | 0.9059 | -- | 24.27 | -0.001 | -0.001 | 0.0016 | 0.0178 | 0.0617 | -- | -- | 63,481.00 | -7.07 | -- | -8.46 | -- | 74.90 | -- | -114.67 | -- | 0.1547 | -8.80 | 0.0977 | -- | -47.25 | -- | -629.37 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Applied DNA Sciences Inc's reporting currency: US Dollar USD
13.33%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| AMH Equity Ltd.as of 08 Aug 2024 | 866.52k | 9.62% |
| L1 Capital Global, Inc.as of 28 May 2024 | 108.00k | 1.20% |
| S.H.N. Financial Investments Ltd.as of 28 May 2024 | 108.00k | 1.20% |
| Armistice Capital LLCas of 31 Mar 2024 | 64.80k | 0.72% |
| Virtu Americas LLCas of 30 Jun 2024 | 19.02k | 0.21% |
| Ground Swell Capital LLCas of 30 Jun 2024 | 15.25k | 0.17% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 8.68k | 0.10% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 5.07k | 0.06% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 3.78k | 0.04% |
| HRT Financial LLCas of 31 Mar 2024 | 2.73k | 0.03% |
More ▼
Data from 31 Mar 2024 - 25 Jul 2024Source: FactSet Research Systems Inc.
